Ubr4 Activators are chemical compounds that enhance the functional activity of Ubr4, a protein encoded by the UBR4 gene. Ubr4, also known as ubiquitin protein ligase E3 component n-recognin 4, plays a significant role in the ubiquitin-proteasome system, a critical pathway for protein degradation and turnover in cellular homeostasis. Activators of Ubr4 can operate through a myriad of biochemical mechanisms, often targeting the intricate network of signaling pathways that regulate the ubiquitination process. For instance, some activators may bind to allosteric sites on the Ubr4 protein, inducing conformational changes that increase its ligase activity. This enhanced ligase activity leads to more efficient tagging of substrates with ubiquitin, marking them for degradation. Others might indirectly increase Ubr4 activity by modulating upstream signaling components, such as kinases or phosphatases, that modulate the functional state of Ubr4 through post-translational modifications.
Furthermore, certain Ubr4 Activators could exert their influence by affecting the levels or activity of E2 ubiquitin-conjugating enzymes, which work in tandem with Ubr4 to facilitate the transfer of ubiquitin to target substrates. By enhancing the activity of E2 enzymes, these activators indirectly boost the efficacy of Ubr4-mediated ubiquitination. Additionally, some chemical activators might interact with proteins that serve as inhibitors or negative regulators of Ubr4, thereby relieving inhibition and promoting Ubr4's catalytic role in the ubiquitin-proteasome pathway. These activators are invaluable tools for dissecting the molecular details of Ubr4's functions and understanding how its activity is fine-tuned within cells. The precise modulation of Ubr4 by these activators underscores the dynamic nature of protein regulation by ubiquitination and highlights the protein's pivotal role in maintaining cellular proteostasis and function.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin raises intracellular cAMP levels, activating protein kinase A (PKA). PKA phosphorylation can enhance the degradation activity of Ubr4 by promoting its interaction with substrates. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG, by inhibiting certain kinases, could enhance Ubr4's ubiquitination capacity by preventing phosphorylation of substrates that are otherwise resistant to Ubr4's action. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
As a PI3K inhibitor, LY294002 can alter downstream signaling pathways. This alteration potentially enhances Ubr4's role in protein degradation pathways by reducing competitive signaling that might otherwise sequester substrates or impede Ubr4's activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 inhibits p38 MAPK, potentially enhancing Ubr4's activity by shifting equilibrium in signaling pathways, favoring those that Ubr4 participates in for protein degradation. | ||||||
Alsterpaullone | 237430-03-4 | sc-202453 sc-202453A | 1 mg 5 mg | $68.00 $312.00 | 2 | |
Alsterpaullone is a cyclin-dependent kinase inhibitor, which may enhance Ubr4's capacity to degrade specific substrates during cell cycle arrest. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate engages in lipid signaling pathways, which can aid in the spatial organization of Ubr4, potentially enhancing its efficiency in substrate recognition within membrane-associated degradation pathways. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin disrupts calcium homeostasis, and the resulting signaling could increase the functional activity of Ubr4 by affecting calcium-dependent degradation pathways. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a broad-spectrum kinase inhibitor that could enhance Ubr4's function by selectively inhibiting kinases that negatively regulate pathways Ubr4 is involved in. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is an ionophore that increases intracellular calcium levels, potentially enhancing Ubr4-mediated signaling pathways through calcium-dependent proteolysis enhancement. | ||||||
Oligomycin A | 579-13-5 | sc-201551 sc-201551A sc-201551B sc-201551C sc-201551D | 5 mg 25 mg 100 mg 500 mg 1 g | $179.00 $612.00 $1203.00 $5202.00 $9364.00 | 26 | |
Oligomycin A inhibits ATP synthase, leading to altered cellular energetics, which could place a higher demand on protein degradation systems, thereby enhancing Ubr4's role in proteostasis. | ||||||